Structure-function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells

被引:15
作者
Ali, Kamilah [1 ]
Lund-Katz, Sissel [2 ]
Lawson, John [1 ]
Phillips, Michael C. [2 ]
Rader, Daniel J. [1 ]
机构
[1] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Med, Philadelphia, PA USA
[2] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Div Gastroenterol Hepatol & Nutr, Philadelphia, PA USA
关键词
apolipoprotein E; cyclooxygenase-2; LDL receptor; vascular smooth muscle cell; heparan sulfate proteoglycan;
D O I
10.1016/j.atherosclerosis.2007.03.038
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Apolipoprotein (apoE) E is a multifunctional protein that plays a critical role in atherogenesis, in part by regulating the intimal proliferation of vascular smooth muscle cells. Recently, a novel cyclooxygenase (COX)-2 pathway was shown to contribute to the anti-proliferative action of human apoE3 in vascular smooth muscle cells (VSMC). Here, we provide insight into the structure-function properties by which apoE mediates these effects. ApoE3 is most effective in promoting COX-2 expression as a lipid-free protein and is less active after lipidation. Alterations in the stability of the helix bundle N-terminal domain of apoE that contains the binding site for the low density lipoprotein (LDL) receptor and heparin do not affect the up-regulation of the COX-2 pathway. In addition, the apoE2, 3, and 4 isoforms are all capable of up-regulating the COX-2 pathway. Finally, the effect of apoE on COX-2 was found to be independent of expression on the VSMC surface of the LDL receptor and heparan sulfate proteoglycans (HSPG). In summary, our data indicates that apoE, particularly in the lipid-free state, can up-regulate COX-2 in murine vascular smooth muscle cells apparently independently of binding to the LDLR, LRP or HSPG. (C) 2007 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 209
页数:9
相关论文
共 45 条
[1]   Comparison of the stabilities and unfolding pathways of human apolipoprotein E isoforms by differential scanning calorimetry and circular dichroism [J].
Acharya, P ;
Segall, ML ;
Zaiou, M ;
Morrow, J ;
Weisgraber, KH ;
Phillips, MC ;
Lund-Katz, S ;
Snow, J .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2002, 1584 (01) :9-19
[2]  
Belton O, 2000, CIRCULATION, V102, P840
[3]   Prostanoids and prostanoid receptors in signal transduction [J].
Bos, CL ;
Richel, DJ ;
Ritsema, T ;
Peppelenbosch, MP ;
Versteeg, HH .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2004, 36 (07) :1187-1205
[4]   LRP: Role in vascular wall integrity and protection from atherosclerosis [J].
Boucher, P ;
Gotthardt, M ;
Li, WP ;
Anderson, RGW ;
Herz, J .
SCIENCE, 2003, 300 (5617) :329-332
[5]   Selective inhibition of cyclooxygenase-2 enhances platelet adhesion in hamster arterioles in vivo [J].
Buerkle, MA ;
Lehrer, S ;
Sohn, HY ;
Conzen, P ;
Pohl, U ;
Krötz, F .
CIRCULATION, 2004, 110 (14) :2053-2059
[6]   The adhesion receptor CD44 promotes atherosclerosis by mediating inflammatory cell recruitment and vascular cell activation [J].
Cuff, CA ;
Kothapalli, D ;
Azonobi, I ;
Chun, S ;
Zhang, YM ;
Belkin, R ;
Yeh, C ;
Secreto, A ;
Assoian, RK ;
Rader, DJ ;
Puré, E .
JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (07) :1031-1040
[7]   Apolipoprotein E and atherosclerosis [J].
Curtiss, LK ;
Boisvert, WA .
CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (03) :243-251
[8]  
Davi G, 1997, CIRCULATION, V96, P69
[9]   APOLIPOPROTEIN-E POLYMORPHISM AND ATHEROSCLEROSIS [J].
DAVIGNON, J ;
GREGG, RE ;
SING, CF .
ARTERIOSCLEROSIS, 1988, 8 (01) :1-21
[10]  
Fisher CA, 1999, J LIPID RES, V40, P93